Paper17519389
Pathobiology of ALK+ anaplastic large-cell lymphoma.
Amin HM and 1 other. Blood, 2007. Cited by 182 papers, by iCite.
Cite this record
ConductScience Library. Pathobiology of ALK+ anaplastic large-cell lymphoma. Papers, record 17519389. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17519389
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphoma, Large-Cell, Anaplastic | Major topic |
| Protein-Tyrosine Kinases | Major topic |
| Anaplastic Lymphoma Kinase | |
| Animals | |
| Humans | |
| Protein Binding | |
| Receptor Protein-Tyrosine Kinases | |
| Signal Transduction |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| K08 CA114395 | NCI NIH HHS | United States | K08CA114395 | PubMed and NIH |
| CA114395 | NCI NIH HHS | United States | K08CA114395 | PubMed and NIH |
Source NIH RePORTER
References137
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3490284 | Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. | Blood | 1986 | https://conductscience.org/library/papers/3490284 | PubMed |
| 2 | 2914325 | Major nucleolar proteins shuttle between nucleus and cytoplasm. | Cell | 1989 | https://conductscience.org/library/papers/2914325 | PubMed |
| 3 | 7889566 | Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. | Cell | 1995 | https://conductscience.org/library/papers/7889566 | PubMed |
| 4 | 7718885 | Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. | Blood | 1995 | https://conductscience.org/library/papers/7718885 | PubMed |
| 5 | 8616716 | Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. | Nat Med | 1996 | https://conductscience.org/library/papers/8616716 | PubMed |
| 6 | 8633037 | Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8633037 | PubMed |
| 7 | 8760799 | Hematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells. | J Exp Med | 1996 | https://conductscience.org/library/papers/8760799 | PubMed |
| 8 | 9053841 | Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. | Oncogene | 1997 | https://conductscience.org/library/papers/9053841 | PubMed |
| 9 | 9057627 | A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. | Blood | 1997 | https://conductscience.org/library/papers/9057627 | PubMed |
| 10 | 11387242 | The cytoplasmic truncated receptor tyrosine kinase ALK homodimer immortalizes and cooperates with ras in cellular transformation. | FASEB J | 2001 | https://conductscience.org/library/papers/11387242 | PubMed |
| 11 | 11395396 | The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. | Am J Pathol | 2001 | https://conductscience.org/library/papers/11395396 | PubMed |
| 12 | 11448921 | In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299. | Clin Cancer Res | 2001 | https://conductscience.org/library/papers/11448921 | PubMed |
| 13 | 2917127 | A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma'). | Br J Haematol | 1989 | https://conductscience.org/library/papers/2917127 | PubMed |
| 14 | 2538681 | Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype. | Leuk Res | 1989 | https://conductscience.org/library/papers/2538681 | PubMed |
| 15 | 2555633 | The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. | Leukemia | 1989 | https://conductscience.org/library/papers/2555633 | PubMed |
| 16 | 1465135 | Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. | Nature | 1992 | https://conductscience.org/library/papers/1465135 | PubMed |
| 17 | 8491186 | The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. | EMBO J | 1993 | https://conductscience.org/library/papers/8491186 | PubMed |
| 18 | 8122112 | Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. | Science | 1994 | https://conductscience.org/library/papers/8122112 | PubMed |
| 19 | 8137429 | The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. | Cell | 1994 | https://conductscience.org/library/papers/8137429 | PubMed |
| 20 | 10552961 | Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. | Blood | 1999 | https://conductscience.org/library/papers/10552961 | PubMed |
Cited by112
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 182 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42631312 | ALK-negative Anaplastic Large Cell Lymphoma Presenting as Back Pain. | J Community Hosp Intern Med Perspect | 2026 | https://conductscience.org/library/papers/42631312 | PubMed |
| 42538745 | Poorly differentiated lung adenocarcinomas with concurrent ALK and CD30 expression: a diagnostic pitfall mimicking ALK-positive anaplastic large-cell lymphoma. | Histopathology | 2026 | https://conductscience.org/library/papers/42538745 | PubMed |
| 42344690 | Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement. | Front Oncol | 2026 | https://conductscience.org/library/papers/42344690 | PubMed |
| 42237783 | Immune checkpoint therapy in pediatric and adolescent lymphomas. | Haematologica | 2026 | https://conductscience.org/library/papers/42237783 | PubMed |
| 40321894 | A novel clustered-based binary grey wolf optimizer to solve the feature selection problem for uncovering the genetic links between non-Hodgkin lymphomas and rheumatologic diseases. | Health Inf Sci Syst | 2025 | https://conductscience.org/library/papers/40321894 | PubMed |
| 39456995 | Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39456995 | PubMed |
| 38676786 | Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors. | Oncol Ther | 2024 | https://conductscience.org/library/papers/38676786 | PubMed |
| 38650799 | Malignancy-Associated Secondary Hemophagocytic Lymphohistiocytosis Mimicking an Infection: A Case Report and Review of the Literature. | Cureus | 2024 | https://conductscience.org/library/papers/38650799 | PubMed |
| 37762644 | Nuclear NPM-ALK Protects Myc from Proteasomal Degradation and Contributes to Its High Expression in Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37762644 | PubMed |
| 37425399 | Patient-led advocacy in ALK-positive lung cancer. | Transl Lung Cancer Res | 2023 | https://conductscience.org/library/papers/37425399 | PubMed |
| 37149665 | New perspectives for targeting therapy in ALK-positive human cancers. | Oncogene | 2023 | https://conductscience.org/library/papers/37149665 | PubMed |
| 36591504 | Current status and challenges of immunotherapy in ALK rearranged NSCLC. | Front Oncol | 2022 | https://conductscience.org/library/papers/36591504 | PubMed |
| 36064579 | ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3. | Oncogene | 2022 | https://conductscience.org/library/papers/36064579 | PubMed |
| 35954222 | Quantitative Acetylomics Uncover Acetylation-Mediated Pathway Changes Following Histone Deacetylase Inhibition in Anaplastic Large Cell Lymphoma. | Cells | 2022 | https://conductscience.org/library/papers/35954222 | PubMed |
| 35939772 | Targeting Anaplastic Lymphoma Kinase in GI Primary Malignancies. | JCO Precis Oncol | 2022 | https://conductscience.org/library/papers/35939772 | PubMed |
| 35836874 | Primary pulmonary anaplastic large cell lymphoma: case report and literature review. | Am J Transl Res | 2022 | https://conductscience.org/library/papers/35836874 | PubMed |
| 34777681 | Interplay between Mitochondrial Metabolism and Cellular Redox State Dictates Cancer Cell Survival. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/34777681 | PubMed |
| 34287231 | Identification and Characterization of Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma Using the SORE6 Reporter. | Curr Issues Mol Biol | 2021 | https://conductscience.org/library/papers/34287231 | PubMed |
| 34043588 | Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming. | J Clin Invest | 2021 | https://conductscience.org/library/papers/34043588 | PubMed |
| 33514657 | Preclinical Evaluation of Gilteritinib on NPM1-ALK-Driven Anaplastic Large Cell Lymphoma Cells. | Mol Cancer Res | 2021 | https://conductscience.org/library/papers/33514657 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALK | 238 | PubTator's text mining | https://conductscience.org/library/genes/238 | NCBI Gene |
| NPM1 | 4869 | PubTator's text mining | https://conductscience.org/library/genes/4869 | NCBI Gene |
| TNFRSF8 | 943 | PubTator's text mining | https://conductscience.org/library/genes/943 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17519389
GET https://conductscience.org/api/papers/v1/17519389/references?page=2